-+ 0.00%
-+ 0.00%
-+ 0.00%
Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.
Share
Listen to the news
Johnson & Johnson is in talks to buy private ophthalmic biotech company Ollin Biosciences for up to $3.4 billion, according to the Financial Times. People familiar with the matter revealed that the deal may be officially announced as soon as this Monday, but there is still a possibility that the negotiations will break down.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending